Image Guided Radiation Therapy for Squamous Cell Carcinoma

Marshfield Medical Center - Weston, Weston, WI
Squamous Cell Carcinoma+1 More ConditionsImage Guided Radiation Therapy - Radiation
Eligibility
18+
All Sexes

Study Summary

This trial studies how well chemotherapy works with surgery and radiation therapy compared to surgery and radiation therapy alone for nasal and paranasal sinus cancer.

Eligible Conditions
  • Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
  • Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 2

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Up to 5 years

Year 5
Overall survival (OS)
Up to 5 years
Structure preservation rate defined as both skull base and orbit being preserved

Trial Safety

Phase-Based Safety

2 of 3
This is further along than 68% of similar trials

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2 Treatment Groups

Arm A (surgery, IMRT, cisplatin, carboplatin)
1 of 2
Arm B (docetaxel, cisplatin, carboplatin, surgery, IMRT)
1 of 2

Active Control

Experimental Treatment

82 Total Participants · 2 Treatment Groups

Primary Treatment: Image Guided Radiation Therapy · No Placebo Group · Phase 2

Arm B (docetaxel, cisplatin, carboplatin, surgery, IMRT)Experimental Group · 8 Interventions: Image Guided Radiation Therapy, Intensity-Modulated Radiation Therapy, Carboplatin, Laboratory Biomarker Analysis, Therapeutic Conventional Surgery, Questionnaire Administration, Docetaxel, Cisplatin · Intervention Types: Radiation, Radiation, Drug, Other, Procedure, Other, Drug, Drug
Arm A (surgery, IMRT, cisplatin, carboplatin)ActiveComparator Group · 7 Interventions: Image Guided Radiation Therapy, Intensity-Modulated Radiation Therapy, Carboplatin, Laboratory Biomarker Analysis, Therapeutic Conventional Surgery, Questionnaire Administration, Cisplatin · Intervention Types: Radiation, Radiation, Drug, Other, Procedure, Other, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensity-Modulated Radiation Therapy
2010
Completed Phase 3
~1680
Carboplatin
FDA approved
Therapeutic Conventional Surgery
2005
Completed Phase 3
~8410
Docetaxel
FDA approved
Cisplatin
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years

Who is running the clinical trial?

ECOG-ACRIN Cancer Research GroupLead Sponsor
110 Previous Clinical Trials
173,603 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,283 Previous Clinical Trials
41,235,316 Total Patients Enrolled
Nabil SabaPrincipal InvestigatorECOG-ACRIN Cancer Research Group

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What ailment or medical issue does Therapeutic Conventional Surgery commonly address?

"Therapeutic Conventional Surgery is an effective means of treating melanoma, head cancer and soft tissue sarcoma." - Anonymous Online Contributor

Unverified Answer

Does this experiment have any available slots for participants?

"This clinical trial, which was brought to light on March 28th 2018, is currently seeking patients. The entry has been updated as recently as December 16th 2021 according to the documents on clinicaltrials.gov" - Anonymous Online Contributor

Unverified Answer

Has the FDA sanctioned Therapeutic Conventional Surgery?

"With some evidence to back up its safety, our team at Power assigned Therapeutic Conventional Surgery a rating of 2 on the 1-3 scale. As this is only Phase 2 trial, there are no findings yet that demonstrate efficacy." - Anonymous Online Contributor

Unverified Answer

Are there any other scholarly examinations that have looked into the effectiveness of Therapeutic Conventional Surgery?

"Presently, there are 1,398 active studies on Therapeutic Conventional Surgery with 473 of them in the third stage. While most of such trials take place at Shanghai medical centres, 81295 sites globally offer treatments related to this surgery." - Anonymous Online Contributor

Unverified Answer

How many healthcare settings are currently administering this experiment?

"This clinical trial is recruiting participants from numerous medical faculties, including Mount Sinai Hospital in Detroit, Michigan, Wayne State University/Karmanos Cancer Institute in Bronx, Montana and Montefiore Medical Center - Moses Campus in Great Falls, Wisconsin." - Anonymous Online Contributor

Unverified Answer

What is the upper limit of individuals participating in this research endeavor?

"Indeed, the information available on clinicaltrials.gov indicates that this medical trial is presently recruiting participants. It was initially posted on March 28th 2018 and recently updated on December 16th 2021. 82 individuals from 100 sites are required for successful completion of the study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.